Biohit Oyj (HLSE:BIOBV) outperformed the Healthcare Equipment industry on the basis of its ROE – producing a higher 35.60% relative to the peer average of 10.61% over the past 12 months. Superficially ...

BIOHIT OYJ is excited to announce the launch of the BIOHIT FAEX Sample System, a stool sample collection and handling solution that can be seamlessly incorporated into any diagnostic workflow.

We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring ...

BIOHIT is excited to announce an agreement with Biomedal to supply its iVYLISA, iVYCHECK and GlutenDetect gluten immunogenic peptide (GIP) tests. Under this agreement, BIOHIT will have exclusive ...

China is planning to introduce new measures to promote the consumption of services, betting that elderly care, healthcare and leisure can offset tepid demand for goods, though analysts say the plan's ...

Biohit Oyj Series B Annual stock financials by MarketWatch. View the latest BIOBV financial statements, income statements and financial ratios.

Dec 22 (Reuters) - Biohit Oyj : * Biohit oyj and Eurobio have signed a distributor agreement regarding diagnostic tests of Biohit * Says agreement is effective immediately, and Eurobio gains exclusive ...

8 December 2025 at 10:30 a.m. EEST New Study Shows Normal GastroPanel® Result Safely Rules Out Need for Gastroscopy Major Cost Savings Possible A newly published clinical study confirms that when ...